Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Timme

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Urology|February 26, 1999
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinomaH L Adler, M A McCurdy, M W Kattan, et al.
Experimental Cell Research|April 1, 1987
Transformation of DNA repair-deficient human diploid fibroblasts with a simian virus 40 plasmidC M Wood, T L Timme, M M Hurt, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1996
Retroviral transduction of transforming growth factor-beta1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutionsT L Timme, G Yang, E Rogers, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomasT C Thompson, S Egawa, D Kadmon, et al.
Oncogene|August 5, 2000
Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosisT L Timme, A Goltsov, S Tahir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Clustered p53 immunostaining: a novel pattern associated with prostate cancer progressionG Yang, A M Stapleton, T M Wheeler, et al.
Cancer Surveys|January 1, 1991
Experimental oncogene induced prostate cancerT C Thompson, D Kadmon, T L Timme, et al.
Mutation Research|July 1, 1990
Expression of the cDNA for the beta subunit of human casein kinase II confers partial UV resistance on xeroderma pigmentosum cellsT Teitz, D Eli, M Penner, et al.
Cancer Gene Therapy|July 14, 2007
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancerH Wang, G Yang, T L Timme, et al.
Endocrinology|March 1, 1994
Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesisT L Timme, L D Truong, V W Merz, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Urology|February 26, 1999
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinomaH L Adler, M A McCurdy, M W Kattan, et al.
Experimental Cell Research|April 1, 1987
Transformation of DNA repair-deficient human diploid fibroblasts with a simian virus 40 plasmidC M Wood, T L Timme, M M Hurt, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1996
Retroviral transduction of transforming growth factor-beta1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutionsT L Timme, G Yang, E Rogers, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomasT C Thompson, S Egawa, D Kadmon, et al.
Oncogene|August 5, 2000
Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosisT L Timme, A Goltsov, S Tahir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Clustered p53 immunostaining: a novel pattern associated with prostate cancer progressionG Yang, A M Stapleton, T M Wheeler, et al.
Cancer Surveys|January 1, 1991
Experimental oncogene induced prostate cancerT C Thompson, D Kadmon, T L Timme, et al.
Mutation Research|July 1, 1990
Expression of the cDNA for the beta subunit of human casein kinase II confers partial UV resistance on xeroderma pigmentosum cellsT Teitz, D Eli, M Penner, et al.
Cancer Gene Therapy|July 14, 2007
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancerH Wang, G Yang, T L Timme, et al.
Endocrinology|March 1, 1994
Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesisT L Timme, L D Truong, V W Merz, et al.
Pageof 6